Cite
HARVARD Citation
Miller, I. et al. (2021). Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study. Epilepsia open. 6 (3), pp. 504-512. [Online].